TwinBeech Capital’s Quest Diagnostics DGX Stock Holding History

TwinBeech Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,913	Closed	-$5.02M	–	628
2025 Q4	$5.02M	Buy	+28,913	New	+$5.26M	0.36%	89
2025 Q1	–	Sell	-20,049	Closed	-$3.02M	–	764
2024 Q4	$3.02M	Buy	+20,049	New	+$3.12M	0.05%	293
2024 Q1	–	Sell	-36,156	Closed	-$4.99M	–	614
2023 Q4	$4.99M	Sell	36,156 -10,889	-23%	-$1.43M	0.08%	271
2023 Q3	$5.73M	Buy	+47,045	New	+$6.27M	0.11%	239
2021 Q1	–	Sell	-6,947	Closed	-$828K	–	492
2020 Q4	$828K	Buy	+6,947	New	+$847K	0.13%	207

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

TwinBeech Capital's DGX Position: Q1 2026 in Review

TwinBeech Capital sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 28,913 shares — an estimated $5.02M sold.

TwinBeech Capital first reported a position in DGX in Q4 2020 and held it in 5 quarters. The position peaked at $5.73M in Q3 2023. 1,069 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

TwinBeech Capital reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
TwinBeech Capital sold 28,913 Quest Diagnostics shares in Q1 2026, an estimated $5.02M.
TwinBeech Capital first reported a position in Quest Diagnostics in Q4 2020 and held it in 5 quarters.
TwinBeech Capital's Quest Diagnostics position peaked at $5.73M in Q3 2023.
1,069 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on TwinBeech Capital's 13F filing for Q1 2026, filed 15 May 2026.